0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight rectal cancer global api manufacturers marketed phase iii drugs landscape 2016.Your search for "" gave back 1533061 results.
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 Summary According to the recently published report 'Histone...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Peritoneal Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
October 2018
Price: USD 2,000.00
Peritoneal Cancer - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2020
Price: USD 2,000.00
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021 Summary RAF Proto...
Catalog:
Global Markets Direct
November 2021
Price: USD 3,500.00
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021 Summary According to the...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Histone Deacetylase 2 - Pipeline Review, H2 2020 Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA,...
Catalog:
Global Markets Direct
November 2022
Price: USD 3,500.00
Cancer Pain - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain...
Catalog:
Global Markets Direct
April 2018
Price: USD 2,000.00
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) Drugs in Development by Therapy...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Peritoneal Cancer - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
March 2018
Price: USD 2,000.00
Histone Deacetylase 3 - Pipeline Review, H2 2020 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) pipeline Target constitutes...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
